[1]DU X, GUO L Z, XIA S J, et al. Atrial fibrillation prevalence, awareness and management in a nationwide survey of adults in China[J]. Heart, 2021, 107(7): 535-541. DOI: 10.1136/heartjnl-2020-317915.
[2]JOHN CAMM A, LIP G Y H, DE CATERINA R, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation [J]. Eur Heart J (2012),33(21): 2719-2747. DOI: 10.1093/eurheartj/ehs253.
[3]SPERTUS J, DORIAN P, BUBIEN R,et al. Development and validation of the Atrial Fibrillation Effect on QualiTy-of-Life (AFEQT) Questionnaire in patients with atrial fibrillation[J]. Circ Arrhythm Electrophysiol, 2011, 4(1): 15-25. DOI: 10.1161/CIRCEP.110.958033.
[4]HRDN M, NYSTRM B, KULICH K, et al. Validity and reliability of a new, short symptom rating scale in patients with persistent atrial fibrillation[J]. Health Qual Life Outcomes, 2009, 7: 65. DOI: 10.1186/1477-7525-7-65.
[5]KOTECHA D, AHMED A, CALVERT M,et al. Patient-reported outcomes for quality of life assessment in atrial fibrillation: a systematic review of measurement properties[J]. PLoS One, 2016, 11(11): e0165790. DOI: 10.1371/journal.pone.0165790.
[6]张欢, 钟理, 陈兴华, 等. 房颤特异性生活质量量表的汉化和信效度评价[J]. 现代预防医学, 2020, 47(3): 471-473, 478.
ZHANG H, ZHONG L, CHEN X H, et al. The chinesization of atrial fibrillation effect on quality-of-life questionnaire and its reliability and validity[J]. Mod Prev Med, 2020, 47(3): 471-473, 478.
[7]HINDRICKS G, POTPARA T, DAGRES N,et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC[J]. Eur Heart J, 2021, 42(5): 373-498. DOI: 10.1093/eurheartj/ehaa612.
[8]何权瀛, 高莹慧. 关于吸烟问题若干名词定义[J]. 中华结核和呼吸杂志, 2009,32(1): 26. DOI:10.3760/cma.j.issn.1001-0939.2009.01.008.
HE Q Y, GAO Y H.Definition of several terms on smoking[J]. Chin J Tuberc Respir Dis, 2009,32(1): 26. DOI:10.3760/cma.j.issn.1001-0939.2009.01.008.
[9]朱丹红, 马冠生. 适量饮酒与健康[J]. 国外医学(卫生学分册), 2006,33(4): 244-247. DOI:10.13325/j.cnki.acta.nutr.sin.2005.05.003.
ZHU D H, MA G S.Drink in moderation with health [J]. Foreign Med Sci Sect Hyg, 2006,33(4): 244-247. DOI:10.13325/j.cnki.acta.nutr.sin.2005.05.003.
[10]WANG Y J, CHEN H, LIU B, et al. A systematic review on the research progress and evolving trends of occupational health and safety management: a bibliometric analysis of mapping knowledge domains[J]. Front Public Health, 2020, 8: 81. DOI: 10.3389/fpubh.2020.00081.
[11]GUHL E, ALTHOUSE A, SHARBAUGH M, et al. Association of income and health-related quality of life in atrial fibrillation[J]. Open Heart, 2019, 6(1): e000974. DOI: 10.1136/openhrt-2018-000974.
[12]WANG J, WANG Q, BAO Z P, et al. The combined effects of patient activation and relational aspects on the quality of life in atrial fibrillation patients[J]. Front Psychol, 2021, 12: 761149. DOI: 10.3389/fpsyg.2021.761149.
[13]DORIAN P, JUNG W, NEWMAN D, et al. The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy[J]. J Am Coll Cardiol, 2000, 36(4): 1303-1309. DOI: 10.1016/s0735-1097(00)00886-x.
[14]汪京嘉, 杜昕, 李玲, 等. 心房颤动患者生活质量及影响因素分析[J]. 心肺血管病杂志, 2014, 33(6): 799-803. DOI: 10.3969/j.issn.1007-5062.2014.06.012.
WANG J J, DU X, LI L, et al. An analysis on quality of life in patients with atrial fibrillation and its influencing factors[J]. J Cardiovasc Pulm Dis, 2014, 33(6): 799-803. DOI: 10.3969/j.issn.1007-5062.2014.06.012.
[15]袁志权, 邬娜, 向颖, 等. 体力活动与房颤患者预后和生活质量的关联研究[J]. 中华疾病控制杂志, 2021, 25(7): 829-836. DOI: 10.16462/j.cnki.zhjbkz.2021.07.017.
YUAN Z Q, WU N, XIANG Y, et al. Association study about physical activity and prognosis and quality of life in patients with atrial fibrillation[J]. Chin J Dis Control Prev, 2021, 25(7): 829-836. DOI: 10.16462/j.cnki.zhjbkz.2021.07.017.
[16]CHENG W H, LO L W, LIN Y J, et al. Cigarette smoking causes a worse long-term outcome in persistent atrial fibrillation following catheter ablation[J]. J Cardiovasc Electrophysiol, 2018, 29(5): 699-706. DOI: 10.1111/jce.13451.
[17]GALLAGHER C, HENDRIKS J M L, ELLIOTT A D, et al. Alcohol and incident atrial fibrillation—A systematic review and meta-analysis[J]. Int J Cardiol, 2017, 246: 46-52. DOI: 10.1016/j.ijcard.2017.05.133.
[18]袁志权, 张欢, 邬娜, 等. 外周血炎症因子与房颤患者生活质量的关联研究[J]. 第三军医大学学报, 2021, 43(13): 1286-1292. DOI: 10.16016/j.1000-5404.202012222.
YUAN Z Q, ZHANG H, WU N, et al. Correlation between peripheral blood inflammatory factors and quality of life in patients with atrial fibrillation[J]. J Third Mil Med Univ, 2021, 43(13): 1286-1292. DOI: 10.16016/j.1000-5404.202012222.
[19]STAERK L, SHERER J A, KO D, et al. Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes[J]. Circ Res, 2017, 120(9): 1501-1517. DOI: 10.1161/CIRCRESAHA.117.309732.
[20]SCHNABEL R B, YIN X Y, GONA P, et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study[J]. Lancet, 2015, 386(9989): 154-162. DOI: 10.1016/S0140-6736(14)61774-8.
[21]HAEUSLER K G, KIRCHHOF P, KUNZE C, et al. Systematic monitoring for detection of atrial fibrillation in patients with acute ischaemic stroke (MonDAFIS): a randomised, open-label, multicentre study[J]. Lancet Neurol, 2021, 20(6): 426-436. DOI: 10.1016/S1474-4422(21)00067-3.
[22]PISTOIA F, SACCO S, TISEO C, et al. The epidemiology of atrial fibrillation and stroke[J]. Cardiol Clin, 2016, 34(2): 255-268. DOI: 10.1016/j.ccl.2015.12.002.
[23]REDDY V, TAHA W, KUNDUMADAM S, et al. Atrial fibrillation and hyperthyroidism: a literature review[J]. Indian Heart J, 2017, 69(4): 545-550. DOI: 10.1016/j.ihj.2017.07.004.
[24]CONNOLLY S J, EZEKOWITZ M D, YUSUF S, et al. Dabigatran versus warfarin in patients with atrial fibrillation[J]. N Engl J Med, 2009, 361(12): 1139-1151. DOI: 10.1056/NEJMoa0905561.
[25]SADANAGA T, SADANAGA M, OGAWA S. Evidence that D-dimer levels predict subsequent thromboembolic and cardiovascular events in patients with atrial fibrillation during oral anticoagulant therapy[J]. J Am Coll Cardiol, 2010, 55(20): 2225-2231. DOI: 10.1016/j.jacc.2009.12.049.
[26]SPRONK H M H, DE JONG A M, VERHEULE S, et al. Hypercoagulability causes atrial fibrosis and promotes atrial fibrillation[J]. Eur Heart J, 2017, 38(1): 38-50. DOI: 10.1093/eurheartj/ehw119.
[27]DUNOIS C. Laboratory monitoring of direct oral anticoagulants (DOACs)[J]. Biomedicines, 2021, 9(5): 445. DOI: 10.3390/biomedicines9050445.